Publications by authors named "Anna Guarini"

Claim this Profile
M
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.
Roberta Soscia, Giovanni Manfredi Assanto, Irene Della Starza, Riccardo Moia, Donatella Talotta, Anna Guarini

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
Alessandro Pulsoni, Simone Ferrero, Maria Elena Tosti, Stefano Luminari, Alessandra Dondi, Anna Guarini

Lancet Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.
Robin Foà, Renato Bassan, Loredana Elia, Alfonso Piciocchi, Stefano Soddu, Anna Guarini

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase.
Deborah Cardinali, Marco Beldinanzi, Michela Ansuinelli, Loredana Elia, Irene Della Starza, Anna Guarini

Leuk Lymphoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
Darina Ocadlikova, Federico Lussana, Nicola Fracchiolla, Massimiliano Bonifacio, Lidia Santoro, Anna Rita Guarini

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients.
Gian Matteo Rigolin, Alice Traversa, Viviana Caputo, Ilaria Del Giudice, Antonella Bardi, Anna Guarini

Br J Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric Experience.
Francesca Fazio, Gianfranco Lapietra, Maria Zaira Limongi, Stefania Intoppa, Maria Laura Milani, Anna Guarini

Mediterr J Hematol Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Francesca R Mauro, Irene Della Starza, Monica Messina, Gianluigi Reda, Livio Trentin, Anna Guarini

Haematologica· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Orietta Spinelli, Alessandra Santoro, Anna Guarini

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sialylation regulates migration in chronic lymphocytic leukemia.
Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Ilaria Del Giudice, Roberta Soscia, Anna Guarini

Haematologica· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
Ilaria Del Giudice, Luca Vincenzo Cappelli, Julio Delgado, Carsten Utoft Niemann, Michael Asger Andersen, Anna Guarini

Br J Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity.
Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Maria Teresa Petrucci, Francesca Fazio, Anna Guarini

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.
Anna Guarini, Giulia Radice, Nadia Peragine, Chiara Buracchi, Maria Stefania De Propris

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
Giovanni Manfredi Assanto, Ilaria Del Giudice, Irene Della Starza, Roberta Soscia, Marzia Cavalli, Anna Guarini

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities.
Luca Vincenzo Cappelli, Danilo Fiore, Jude M Phillip, Liron Yoffe, Filomena Di Giacomo, Anna Guarini

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Roberta Soscia, Irene Della Starza, Lucia Anna De Novi, Caterina Ilari, Michela Ansuinelli, Anna Guarini

Hematol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Anna Guarini

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia.
Irene Della Starza, Lucia Anna De Novi, Loredana Elia, Vittorio Bellomarino, Marco Beldinanzi, Anna Guarini

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response.
Nadia Peragine, Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Francesca Romana Mauro, Anna Guarini

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation.
Maria Cristina Puzzolo, Massimo Breccia, Paola Mariglia, Gioia Colafigli, Sara Pepe, Anna Guarini

J Clin Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
Irene Della Starza, Lucia A De Novi, Alessandra Santoro, Domenico Salemi, Orietta Spinelli, Anna Guarini

J Mol Diagn· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
Maria Stefania De Propris, Paolo Musiu, Stefania Intoppa, Maria Grazia Nardacci, Alessandra Pucciarini, Anna Guarini

Br J Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia.
Francesca Fazio, Gabriella Cunsolo, Francesca Mancini, Maria Stefania De Propris, Alfonso Piciocchi, Anna Guarini

Leuk Lymphoma· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial.
Giovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, Walter Barberi, Laura Santodonato, Anna Guarini

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
Francesca Romana Mauro, Francesca Paoloni, Stefano Molica, Gianluigi Reda, Livio Trentin, Anna Guarini

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis